PengPJ,LvBJ,TangC,LiaoH,LinZ,LiuYM, 2015.Phase ii trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma,Drug Des Devel Ther 9 6401 -5
PangH,FengT,LuHL,MengQW,ChenXS,ShenQ, 2016.Efficacy and safety of nedaplatin in advanced breast cancer therapy,Cancer Invest 34 167 -72
WangH,ZhuXL,HuangJ,ChenPS,HanSH,YanX, 2016.Nedaplatin sensitization of cisplatin-resistant human non-small cell lung cancer cells,Oncol Lett 11 2566 -72
LiCH,LiuMY,LiuW,LiDD,CaiL, 2014.Randomized control study of nedaplatin or cisplatin concomitant with other chemotherapy in the treatment of advanced nonsmall cell lung cancer,Asian Pac J Cancer Prev 15 731 -6
KajiuraS,HosokawaA,YoshitaH,UedaY,UedaA,MiharaH, 2016.Phase I study of docetaxel plus nedaplatin in patients with metastatic or recurrent esophageal squamous cell carcinoma after cisplatin plus 5-fluorouracil treatment,Am J Clin Oncol 39 13 -7
KucharzJ,Michalowska-KaczmarczykA,Zygulska AnetaL,WojtakJ,PawlikW,Herman RomanM, 2016.Bradycardia as a rare symptom of cisplatin cardiotoxicity: A case report,Oncol Lett 11 2297 -9
SchlumbrechtMP,HehrK, 2015.Cisplatin-induced bradycardia and the importance of the QT interval,J Oncol Pharm Pract 21 157 -60
NaitoY,KubotaK,OhmatsuH,GotoK,NihoS,YohK, 2011.Phase II study of nedaplatin and docetaxel in patients with advanced squamous cell carcinoma of the lung,Ann Oncol 22 2471 -5
TakekumaM,HirashimaY,ItoK,TsubamotoH,TabataT,ArakawaA, 2012.Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A kansai clinical oncology group study,Gynecol Oncol 126 341 -5
CaoW,XuC,LouG,JiangJ,ZhaoS,GengM, 2009.A phase II study of paclitaxel and nedaplatin as frst-line chemotherapy in patients with advanced esophageal cancer,Jpn J Clin Oncol 39 582 -7